The women who have been exposed to the states present a minor risk of hospitalizations due to cardiac failure.
- ADRIÁN AGUIRRE
- 20/06/2021
- 16:16.
Agreed with the Foundation of Cancer of Mama (FUCAM), one of each site will be unrolled breast cancer during his life and 60% of women with breast cancer does not have any risk factor.
96% of cases that are detected in time can be curable, with treating less invasive and cost, details FUCAM, but a medicine used against the cholesterol you can help protect it corazón of the women of the secondary effects adverse of the temperament treatment of breast cancer.
A studio of the American Heart Association published the 6th of January of 2021 plant the hypothesis of those states can reduce the risk of cardiotoxicity associated with medications for the Cancer (anthracyclines y trastuzumab).
Medicine for cholesterol protectorate corazón of adverse effects of treatment of breast cancer
Mayo Clinic define load states as medicines that can reduce the cholesterol in the body of the people.
Clinic Dicha explains that states trabajan bloqueando una sustancia what is our organism needed to generate cholesterol.
The one who blocks the cholesterol no series the only benefit of the states, señala Mayo Clinic, has been using it with a minor risk of cerebrovascular accidents y cardiac diseases (remember that there is no good car).
The investigators of the American Heart Association use data bases to conduct a cohort study in females of 66 years or less with a cardiac failure previa that receive chemotherapy with anthracyclines o trastuzumab, with the finalization of studying the association of the exhibition and the states with the hospitalization or visit to the emergency department for problems of corazón after the tempering treatment against the breast cancer.
The period of evaluation of the study of ten years (2007-2017) and compared to women with and without exposure to states.
“We will discover that the women who lived there were exposed to the states presents a minor risk of hospital presentations by cardio case after receiving chemotherapy tempered by breast cancer involucrando anthracyclines, and no significant trends tend to be a minor minor when using the trastuzumab“, concluded the specialists.